Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma(MM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06932562
What this trial is testing

Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 1,000
Not applicableStudy completedNCT04659798
What this trial is testing

Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice

Who this might be right for
Multiple MyelomaImmunoglobulin Light-chain Amyloidosis
Takeda 240
Testing effectiveness (Phase 2)Looking for participantsNCT05908409
What this trial is testing

IDP-121 in Patients With Relapsed/Refractory Hematologic Malignancies

Who this might be right for
Multiple Myeloma (MM)Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedDouble Hit Lymphoma+3 more
IDP Discovery Pharma S.L. 37
Not applicableLooking for participantsNCT07305337
What this trial is testing

Randomised Controlled Trial of Artificial Intelligence-assisted Health Education

Who this might be right for
LeukaemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaLymphoma
Zhongnan Hospital 196
Not applicableStudy completedNCT05673967
What this trial is testing

Real-World Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Regeneron Pharmaceuticals 62
Early research (Phase 1)Ended earlyNCT00460460
What this trial is testing

Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies

Who this might be right for
Lymphoma
AstraZeneca 75
Testing effectiveness (Phase 2)Study completedNCT02384083
What this trial is testing

Filanesib (ARRY-520) in Combination With Pomalidomide and Dexamethasone for Relapsed/Refractory (R/R) Multiple Myeloma (MM) Patients

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 47
Not applicableStudy completedNCT02559583
What this trial is testing

Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America

Who this might be right for
Multiple MyelomaLeukemiaLymphoid+2 more
Janssen-Cilag Ltd. 5,443
Large-scale testing (Phase 3)Active Not RecruitingNCT04071457
What this trial is testing

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 1,100
Not applicableEnded earlyNCT02394210
What this trial is testing

Post-authorisation Study of Biological Relapse in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 415
Testing effectiveness (Phase 2)Study completedNCT01394354
What this trial is testing

Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma in Relapse
University Hospital Freiburg 34
Testing effectiveness (Phase 2)Looking for participantsNCT06627751
What this trial is testing

Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease

Who this might be right for
Extramedullary Disease in Multiple MyelomaRecurrent Multiple MyelomaRefractory Multiple Myeloma
Roswell Park Cancer Institute 28
Testing effectiveness (Phase 2)Looking for participantsNCT06087653
What this trial is testing

Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Starton Therapeutics, Inc 24
Testing effectiveness (Phase 2)Study completedNCT00891618
What this trial is testing

Acupuncture for Chemo-Induced Peripheral Neuropathy

Who this might be right for
LymphomaMyelomaPeripheral Neuropathy
M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00617591
What this trial is testing

Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 57
Not applicableNot Yet RecruitingNCT06888856
What this trial is testing

Multiple Myeloma is a Hematologic Malignancy Characterized by the Accumulation of Malignant Plasma Cells in the Bone Marrow. Despite Advances in Treatment, Many Patients Experience Disease Relapse. Bispecific Antibodies Offer an Innovative Therapeutic Approach, But Approximately 30%-40% of Patients

Who this might be right for
Multiple Myeloma (MM)
Tel-Aviv Sourasky Medical Center 200
Early research (Phase 1)Study completedNCT00317798
What this trial is testing

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganMultiple Myeloma and Plasma Cell Neoplasm
University of Rochester 18
Large-scale testing (Phase 3)Looking for participantsNCT07393282
What this trial is testing

Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

Who this might be right for
High Risk Smoldering Multiple Myeloma (HR-SMM)
Regeneron Pharmaceuticals 270
Testing effectiveness (Phase 2)WithdrawnNCT03608501
What this trial is testing

Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell Transplantation

Who this might be right for
Multiple Myeloma
Takeda
Early research (Phase 1)UnknownNCT05020639
What this trial is testing

TQB3820 in Patients With Hematological Malignancies

Who this might be right for
Hematological Malignancies
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 116
Next Page